Education Center

Contents

Opioid-Sparing Pain Control in Outpatient Total Joint Arthroplasty

John W. Barrington, MD

Addressing the Opioid Epidemic With Multimodal Pain Management

Michael A. Kelly, MD

Comprehensive Care for Joint Replacement (CJR) Bundle Expense in Perioperative Pain Management

Susan D. Bear, PharmD, BCPS

The Role of Liposomal Bupivacaine in Value-Based Care

Richard Iorio, MD

Click here to read the supplement

Contents

Opioid-Sparing Pain Control in Outpatient Total Joint Arthroplasty

John W. Barrington, MD

Addressing the Opioid Epidemic With Multimodal Pain Management

Michael A. Kelly, MD

Comprehensive Care for Joint Replacement (CJR) Bundle Expense in Perioperative Pain Management

Susan D. Bear, PharmD, BCPS

The Role of Liposomal Bupivacaine in Value-Based Care

Richard Iorio, MD

Click here to read the supplement

Contents

Opioid-Sparing Pain Control in Outpatient Total Joint Arthroplasty

John W. Barrington, MD

Addressing the Opioid Epidemic With Multimodal Pain Management

Michael A. Kelly, MD

Comprehensive Care for Joint Replacement (CJR) Bundle Expense in Perioperative Pain Management

Susan D. Bear, PharmD, BCPS

The Role of Liposomal Bupivacaine in Value-Based Care

Richard Iorio, MD

Click here to read the supplement

• Historical Overview
• Mechanistic Basis for a Cardiovascular Hazard
• Evidence from Meta-Analyses
• Cardiovascular Risk
• Implications for Patient Management

Faculty/Faculty Disclosure:
Gary Rouff, MD
Clinical Professor of Family Medicine,
Department of Family Practice,
Michigan State University
College of Medicine, Director of Clinical
Research, Westside Family Medical Center
Kalamazoo, MI

Dr. Rouff discloses that he has no real or apparent conflict of interest to report

Click Here to Read Supplement

• Historical Overview
• Mechanistic Basis for a Cardiovascular Hazard
• Evidence from Meta-Analyses
• Cardiovascular Risk
• Implications for Patient Management

Faculty/Faculty Disclosure:
Gary Rouff, MD
Clinical Professor of Family Medicine,
Department of Family Practice,
Michigan State University
College of Medicine, Director of Clinical
Research, Westside Family Medical Center
Kalamazoo, MI

Dr. Rouff discloses that he has no real or apparent conflict of interest to report

Click Here to Read Supplement

• Historical Overview
• Mechanistic Basis for a Cardiovascular Hazard
• Evidence from Meta-Analyses
• Cardiovascular Risk
• Implications for Patient Management

Faculty/Faculty Disclosure:
Gary Rouff, MD
Clinical Professor of Family Medicine,
Department of Family Practice,
Michigan State University
College of Medicine, Director of Clinical
Research, Westside Family Medical Center
Kalamazoo, MI

Dr. Rouff discloses that he has no real or apparent conflict of interest to report

Click Here to Read Supplement

Table of Contents

• AVAHO 2016 Abstract Index
• Poster Abstracts

Table of Contents

• AVAHO 2016 Abstract Index
• Poster Abstracts

Table of Contents

• AVAHO 2016 Abstract Index
• Poster Abstracts

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).

A supplement to Federal Practitioner. This supplement is sponsored by Organogenesis, Inc.

Chronic non-healing wounds are a major problem for patients and wound care practitioners in the VA system. It is self-evident among experienced wound care practitioners that wound infection can delay (or completely prevent) wound healing. Biofilm is a common form of wound contamination that is now recognized to be a major factor in delaying the healing of wounds.

 

This supplement discusses the awareness of the biology of biofilm, its prevalence, its clinical significance, and optimal treatment approaches that need to be improved. The supplement also reviews the current status of evidence-based management of biofilm with a focus on the optimal use of PuraPly™ Antimicrobial, a native purified collagen matrix containing the antimicrobial polyhexamethylene biguanide (PHMB).

Click here to read supplement

Click here to read supplement

Click here to read supplement